IHCH-8110

IHCH-8110 is a peripherally selective and non-hallucinogenic serotonin 5-HT 2A receptor agonist.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

IHCH-8110 is a peripherally selective and non-hallucinogenic serotonin 5-HT 2A receptor agonist. IHCH-8110 shows affinity for the serotonin 5-HT 2A , 5-HT 2B , and 5-HT 2C receptors (K i = 48 nM, 102 nM, and 302 nM, respectively). The drug is a partial agonist at the serotonin 5-HT 2A receptor with an of 93–479 nM and of 45–68%.

It is also a partial agonist of the serotonin 5-HT 2C receptor but not of the serotonin 5-HT 2B receptor, where it instead functioned as an antagonist. The drug did not interact with other serotonin or dopamine receptors.

IHCH-8110 is highly peripherally selective and does not produce the head-twitch response, a behavioral proxy of psychedelic effects, nor affect locomotor activity in rodents. It has been found to enhance CD8 + T cell-mediated antitumor immunity and inflammation and to suppress colorectal cancer progression, effects mediated by activation of serotonin 5-HT 2A receptors on enteric glial cells that results in increased CXCL10 and interleukin-18 expression.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1376723446 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.